Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Prelude Therapeutics Incorporated (PRLD) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$5.70M |
|
$-13.92M |
|
-- |
|
$5.70M |
|
$21.16M |
|
$-15.45M |
|
$1.53M |
|
$-13.92M |
|
$-13.92M |
|
$-13.92M |
|
$-13.92M |
|
$-13.92M |
|
$-13.92M |
|
$-15.45M |
|
$-15.41M |
|
98.39M |
|
98.39M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$154.90M |
|
$4.40M |
|
$34.47M |
|
$189.36M |
|
$38.04M |
|
-- |
|
$17.59M |
|
$55.63M |
|
$133.73M |
|
$133.73M |
|
$133.73M |
|
79.76M |
|
| Cash Flow Statement Financials | |
$-37.26M |
|
$-57.00M |
|
$85.51M |
|
$38.49M |
|
$29.73M |
|
$-8.76M |
|
$4.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.07 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-270.93% |
|
-270.93% |
|
-- |
|
-244.06% |
|
-244.06% |
|
$-37.26M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-10.41% |
|
-10.41% |
|
-7.35% |
|
-10.41% |
|
$1.68 |
|
$-0.38 |
|
$-0.38 |
|